Heron Therapeutics
HRTX
HRTX
149 hedge funds and large institutions have $115M invested in Heron Therapeutics in 2023 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 45 increasing their positions, 48 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
30% less capital invested
Capital invested by funds: $163M → $115M (-$48.3M)
45% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 29
67% less call options, than puts
Call options by funds: $20K | Put options by funds: $60K
Holders
149
Holding in Top 10
3
Calls
$20K
Puts
$60K
Top Buyers
| 1 | +$2.56M | |
| 2 | +$1.51M | |
| 3 | +$1.5M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$1.16M |
| 5 |
CC
Clearline Capital
New York
|
+$669K |
Top Sellers
| 1 | -$5.12M | |
| 2 | -$3.84M | |
| 3 | -$1.33M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$1.25M |
| 5 |
BlackRock
New York
|
-$1.19M |